Tomita, Urara
Ishimoto, Yoko
Ri, Masaki
Kawase, Yumi
Hizukuri, Yoshiyuki
Maru, Chikako
Nanai, Kayoko
Nakamura, Ryuichi
Nakayama, Makiko
Oguchi-Oshima, Keiko
Sumi, Hiroyuki
Ohtsuka, Toshiaki
Iida, Shinsuke
Agatsuma, Toshinori
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 8 November 2023
Accepted: 20 February 2024
First Online: 1 March 2024
Competing interests
: This study was funded by Daiichi Sankyo, Tokyo, Japan. S.I. reports grant from Daiichi Sankyo, Janssen, Sanofi, Takeda, Ono, Bristol-Myers Squibb, Abbvie, Novartis, Pfizer, Amgen, Glaxo Smith Klein, Chugai, Otsuka, Alexion, Celgene, and Shionogi; Honoraria from Janssen, Sanofi, Takeda, Ono, and Bristol-Myers Squibb. T.A. is Board of Director of Daiichi Sankyo. U.T., Y.I., Y.K., C.M., K.N., R.N., Y.H., M.N., H.S. and T.O. are employees of Daiichi Sankyo. Other authors declare no competing interests.